OpenAlex
PricingAboutJobs
Log inGet started
Work

Immunotherapy in myasthenia gravis in the era of biologics

HTML

Year: 2018
Type: review
Source: Nature Reviews Neurology
DOI: 10.1038/s41582-018-0110-z
Author: Marinos C. Dalakas
Institutions: Thomas Jefferson University, National and Kapodistrian University of Athens
Language: English

Topic: Myasthenia Gravis and Thymoma
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: myasthenia gravis, immunotherapy, biologics, eculizumab, rituximab, anti-CD20 monoclonal antibody, belimumab, efgartigimod, complement C5, B-cell depletion, BAFF, anti-cytokine therapy, immune checkpoint inhibitors, steroid-sparing therapy, refractory myasthenia gravis, treatment algorithm
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2904124424
FWCI: 2.26
Cites: 105
Cited by: 195
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security